Single Cell with One Particle Entry (SCOPE) for Study of HIV Infection

用于 HIV 感染研究的单细胞单粒子进入 (SCOPE)

基本信息

  • 批准号:
    8146689
  • 负责人:
  • 金额:
    $ 233.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-30 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Provided by the applicant) Abstract: Through infection of CD4 positive (CD4+) T lymphocytes, the Human Immunodeficiency Virus type 1 (HIV-1) has claimed twenty-five million lives since its discovery in 1983. Although it has been well established that HIV-1 initiates a T cell infection by binding to CD4 and chemokine coreceptors on the cell surface, the early events in HIV-1 infection of CD4+ T cells remain poorly understood. A variety of different techniques have been used over the years to study mechanisms of HIV-1 entry. However, one technical limitation that is inherent in all these methods is the inability to track the fate of a single HIV-1 virion from the very beginning of viral entry to chromosomal integration. In all these experiments, a population of viruses and cells were incubated and measured. Because each entry event can lead to proviral DNA integration with a finite probability, it is therefore difficult to establish a causative link between entry pathway and productive infection. The goal of this project is to develop a set of nanoscopic and novel technologies that we can harness to define the pathway and interactions by which HIV-1 infects CD4+ T cells. We are developing a technique based on optical tweezers that can manipulate a single HIV-1 virion, deliver it to CD4+ T cell and thus allows us to determine the fate of CD4+ T cell upon entry by a single virion. This technique will allow us to unambiguously define the molecular mechanisms of HIV-1 infection. Furthermore, we propose to measure directly the interactions between a single HIV-1 virion and receptors in the context of a live T cell. Collectively, these studies will contribute to a definitive and quantitative understanding of early events in HIV infection, which may help therapeutic development that is aimed to block HIV-1 entry to CD4+ T cells. The techniques developed herein can be useful for studying cellular uptake of not only viruses but other molecules, macromolecular assemblies and nanoparticles, and are applicable to a wide-range of ligand-receptor interactions on the cell surface. Public Health Relevance: The early events in HIV infection of CD4+ T cells are poorly understood. This proposal aims to develop a set of nanoscopic and other novel techniques to study HIV infection of CD4+ T cells in real time, one virion at a time. If successful, the results from this study will establish for the first time a causative link between HIV entry pathway and the productive infection of CD4+ T cells, which will help therapeutic development that is aimed to block HIV-1 entry to CD4+ T cells.
描述(申请人提供) 摘要:通过感染CD4阳性(CD4+)T淋巴细胞,人类免疫缺陷病毒1型(HIV-1)自1983年发现以来已经夺取了二十万五百万的生命。尽管已经很好地确定,HIV-1通过与CD4和CYOKINE CORECEPTORS结合了较早的CD4+ CD4+ TCD4+ TCD4+ TIMED FIMED+ TECTION tO启动T细胞感染。多年来,已经使用了多种不同的技术来研究HIV-1进入的机制。但是,在所有这些方法中固有的一种技术限制是从病毒进入到染色体整合的一开始就无法跟踪单个HIV-1病毒体的命运。在所有这些实验中,对病毒和细胞的群体进行了孵育和测量。由于每个入口事件都可以导致有限的概率导致前毒性DNA整合,因此很难在入口途径和生产性感染之间建立因果关系。该项目的目的是开发一组纳米镜和新型技术,我们可以利用这些技术来定义HIV-1感染CD4+ T细胞的途径和相互作用。我们正在开发一种基于光学镊子的技术,该技术可以操纵单个HIV-1病毒体,将其输送到CD4+ T细胞中,从而使我们能够在通过单个病毒体进入时确定CD4+ T细胞的命运。该技术将使我们能够明确定义HIV-1感染的分子机制。此外,我们建议在活T细胞的背景下直接测量单个HIV-1病毒体与受体之间的相互作用。总的来说,这些研究将有助于对艾滋病毒感染中早期事件的明确和定量理解,这可能有助于治疗性发育,旨在阻止HIV-1进入CD4+ T细胞。本文开发的技术可用于研究不仅病毒的细胞摄取,而且还可用于其他分子,大分子组件和纳米颗粒,并且适用于细胞表面上的大量配体 - 受体相互作用。 公共卫生相关性:CD4+ T细胞艾滋病毒感染的早期事件的理解很少。该建议旨在开发一组纳米镜和其他新型技术,以实时研究CD4+ T细胞的HIV感染,一次是一种病毒粒子。如果成功,这项研究的结果将首次建立HIV进入途径与CD4+ T细胞的生产性感染之间的因果关系,这将有助于治疗性发育,旨在阻止HIV-1进入CD4+ T细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wei Cheng其他文献

Wei Cheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wei Cheng', 18)}}的其他基金

Mechanisms of B cell responses to particulate antigens
B 细胞对颗粒抗原的反应机制
  • 批准号:
    10296438
  • 财政年份:
    2021
  • 资助金额:
    $ 233.25万
  • 项目类别:
Mechanisms of B cell responses to particulate antigens
B 细胞对颗粒抗原的反应机制
  • 批准号:
    10437883
  • 财政年份:
    2021
  • 资助金额:
    $ 233.25万
  • 项目类别:
Mechanisms of B cell responses to particulate antigens
B 细胞对颗粒抗原的反应机制
  • 批准号:
    10652473
  • 财政年份:
    2021
  • 资助金额:
    $ 233.25万
  • 项目类别:
Single Cell with One Particle Entry (SCOPE) for Study of HIV Infection
用于 HIV 感染研究的单细胞单粒子进入 (SCOPE)
  • 批准号:
    8458458
  • 财政年份:
    2011
  • 资助金额:
    $ 233.25万
  • 项目类别:

相似国自然基金

Fosl1通过调控CD4+T淋巴细胞分化参与脓毒症性肺损伤的机制研究
  • 批准号:
    81901948
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
  • 批准号:
    10549648
  • 财政年份:
    2023
  • 资助金额:
    $ 233.25万
  • 项目类别:
Structural Biology Core
结构生物学核心
  • 批准号:
    10549644
  • 财政年份:
    2023
  • 资助金额:
    $ 233.25万
  • 项目类别:
Non-canonical epitope presentation and antigen processing by MHC-E
MHC-E 的非典型表位呈递和抗原加工
  • 批准号:
    10801509
  • 财政年份:
    2023
  • 资助金额:
    $ 233.25万
  • 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 233.25万
  • 项目类别:
Single-cell Proteogenomic profiling of HIV-1 reservoir cells
HIV-1 储存细胞的单细胞蛋白质组学分析
  • 批准号:
    10675812
  • 财政年份:
    2023
  • 资助金额:
    $ 233.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了